Understand the source comparison
Pinealon Beginners Guide: Tripeptide Comparison
Researchers new to bioregulator peptides often ask how Pinealon compares to other short-chain neuropeptides in mechanism, stability, and research utility. The table below contrasts Pinealon (EDR) with structurally similar compounds based on peer-reviewed resea
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Researchers new to bioregulator peptides often ask how Pinealon compares to other short-chain neuropeptides in mechanism, stability, and research utility. The table below contrasts Pinealon (EDR) with structurally similar compounds based on peer-reviewed research and synthesis specifications from Real Peptides.
- Pinealon
- Glu-Asp-Arg (EDR)
- Genomic regulation via chromatin binding; upregulates neuronal stress-response genes, synaptic proteins
- 100–500 mcg daily SC, 10–20 day cycles
- 24–36 months
- Cognitive aging, synaptic plasticity, neuroprotection models
- Best for genomic-level intervention studies where cumulative gene expression changes are the endpoint. Not suitable for acute behavioral pharmacology
- Epithalon Peptide
- Ala-Glu-Asp-Gly (AEDG)
- Telomerase activation, circadian rhythm regulation via epiphyseal signaling
- 5–10 mg per cycle (5–10 days), SC or IM
- Aging research, circadian biology, cellular senescence models
- Mechanistically distinct from Pinealon despite both being tetrapeptide bioregulators. Epithalon acts on telomeres, Pinealon on transcription; protocols rarely overlap
- Selank Amidate Peptide
- Thr-Lys-Pro-Arg-Pro-Gly-Pro (tuftsin derivative)
- Anxiolytic via GABAergic and serotonergic modulation; enkephalinase inhibition
- 250–500 mcg daily, intranasal or SC
- 18–24 months
- Anxiety models, stress response, immune modulation
- Acute anxiolytic action within hours makes Selank useful for immediate behavioral endpoints; Pinealon's delayed genomic effects serve different experimental designs
- Thymalin
- Polypeptide complex (thymic extract, 30+ sequences)
- Immunomodulation via T-cell maturation and cytokine regulation
- 5–10 mg per dose, 5–10 day cycles
- Immune senescence, autoimmune models, infection resistance
- Not a neuropeptide. Included for comparison because both Thymalin and Pinealon are classified as bioregulators; mechanisms and applications non-overlapping